Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

THE TRUTH ABOUT: Polarityte | History Defined

PolarityTE's Return On Capital Employed Overview

According to data from Benzinga Pro, during Q1, PolarityTE's (NASDAQ:PTE) reported sales totaled $741.00 thousand. Despite a 55.99% increase in earnings, the company posted a loss of $3.77 million.

Benzinga · Jun 21, 2022

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga · May 13, 2022

Earnings Outlook For PolarityTE

PolarityTE (NASDAQ:PTE) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that PolarityTE will report an earnings per share (EPS) of $-0.08.

Benzinga · May 13, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

PolarityTE Shares Jump After FDA Regenerative Medicine Advanced Therapy Designation (RMAT) for SkinTE

The U.S. Food and Drug Administration (FDA) has granted a Regenerative Medicine Advanced Therapy (RMAT) designation to PolarityTE’s (NASDAQ: PTE) SkinTE under the its open investigational new drug application (IND).

Benzinga · May 13, 2022

The Daily Biotech Pulse: FDA Orphan Drug Tags For Neurocrine, Editas Candidates; Sale of BridgeBio's PRV; RMAT Designation For PolarityTE's Product

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga · May 13, 2022

Looking Into PolarityTE's Return On Capital Employed

Benzinga Pro data, PolarityTE (NASDAQ:PTE) reported Q4 sales of $1.04 million. Earnings fell to a loss of $8.57 million, resulting in a 739.18% decrease from last quarter.

Benzinga · Mar 31, 2022

Recap: PolarityTE Q4 Earnings

PolarityTE (NASDAQ:PTE) reported its Q4 earnings results on Wednesday, March 30, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Benzinga · Mar 30, 2022

Read news from The Economist, FT, and more,
with one subscription

Earnings Preview: PolarityTE

PolarityTE (NASDAQ:PTE) is set to give its latest quarterly earnings report on Wednesday, 2022-03-30. Here's what investors need to know before the announcement. Analysts estimate that PolarityTE will report an earnings per share (EPS) of $-0.09.

Benzinga · Mar 29, 2022

PolarityTE Q4 2021 Earnings Conference Call On March 30, 2022 At 08:30 AM ET

PolarityTE (NASDAQ:PTE) will host a conference call at 08:30 AM ET on March 30, 2022, to discuss Q4 2021 earnings results. How to Attend PolarityTE (PTE) Conference Call Follow this link to access the live webcast.

Benzinga · Mar 17, 2022

PolarityTE's SkinTE Meets Primary, Secondary Goals In Venous Leg Ulcers Trial

PolarityTE Inc (NASDAQ: PTE) has announced

Benzinga · Feb 22, 2022

FDA Approves PolarityTE's Phase 3 Study Of SkinTE In Chronic Cutaneous Ulcer

The

Benzinga · Jan 18, 2022

Coverage From

Benzinga

Organisations

US Food and Drug Administration

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

United States

430,436 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.